Request more information from our team or explore ordering options and resources to bring Myriad Oncology testing into your practice.
Request informationBack
Resources
Confirm your information below and submit the form today to schedule a meeting with a Myriad Account Executive. We can’t wait to partner with you.
By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.
Contact Information
You rely on specific and clinically actionable oncology test answers to ensure that each patient receives the personalized, stage-specific interventions they need. Myriad has built a comprehensive oncology-focused genetic and tumor genomic testing portfolio to do just that. Designed to empower you at each step across their patient journey — from screening to treatment, from previvorship to survivorship — we provide the insights you count on, with extensive patient and staff support services along the way.
We offer a suite of services and workflow solutions designed to streamline germline and tumor genomic testing without added cost to the clinic or patient.
While tumor genomic testing has long been recommended for patients with metastatic or advanced cancers, ASCO now supports the expansion of multigene germline testing to better ensure eligible patients and their families receive optimal care.3
Ordering both germline and tumor genomic testing from Myriad ensures consolidated and concordant results at each step, empowering you to deliver a truly personalized treatment strategy for each patient.
With Myriad, you will benefit from a streamlined experience for obtaining consolidated germline and tumor genomic results:
Myriad has invested over 30 years into developing tests and solutions that help you, your patients, and your practice by providing the best answers and care possible. See how we can help streamline your patient care:
Helpful tools to quickly identify patients who meet criteria for germline testing based on guidelines
Pre-test education as live, point-of-care sessions with a board-certified Genetic Counselor, including documented case notes
Easy ordering options including paper, online, virtual, and EMR for seamless ordering and access to results
Transparent pricing with personalized cost estimates, financial assistance, and other affordability options including direct pay
Tissue specialists ensure tumor tissue is quickly processed, and any unused tissue is promptly returned to the pathology lab
Consolidated germline and tumor genomic results are available within 14 days
The Myriad Management Tool streamlines germline and tumor genomic results into an easy-to-follow report
Medical Science Liasons support you and your team in addressing clinical, testing, and results-related questions
Post-test results consults with board-certified Genetic Counselors can be scheduled or are available on demand
Myriad’s Variant Classification Program includes a Lifetime Reclassification Commitment to send amended reports if a VUS is reclassified and is clinically
View discussions about current topics in genetic and tumor genomic testing with Myriad’s medical experts and external special guests. See more details on upcoming events and view past recordings.
Stay current with clinical validation and utility publications and more.
Find the Myriad documents and forms you need right here.
References:
Myriad Genetics, MyRisk, Precise Tumor, MyChoice, Prolaris, BRACAnalysis CDx, RiskScore, and their respective logos, are registered trademarks of Myriad Genetics, Inc. and its subsidiaries in the United States and other jurisdictions. EndoPredict and the EndoPredict logo are either trademarks or registered trademarks of Eurobio Scientific.